We've found
14,731
archived clinical trials in
Psychiatric
We've found
14,731
archived clinical trials in
Psychiatric
Intensive Weekend Retreat Multi-Couple Group Therapy for PTSD
Updated: 12/31/1969
Multi-Couple Group Intervention for PTSD
Status: Enrolling
Updated: 12/31/1969
Intensive Weekend Retreat Multi-Couple Group Therapy for PTSD
Updated: 12/31/1969
Multi-Couple Group Intervention for PTSD
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
KP415 Classroom Study in Children (6-12 Years of Age) With ADHD
Updated: 12/31/1969
A Multicenter, Dose-Optimized, Double-Blind, Randomized, Placebo-Controlled, Parallel Efficacy Laboratory Classroom Study With KP415 in Children With Attention-Deficit/Hyperactivity Disorder
Status: Enrolling
Updated: 12/31/1969
KP415 Classroom Study in Children (6-12 Years of Age) With ADHD
Updated: 12/31/1969
A Multicenter, Dose-Optimized, Double-Blind, Randomized, Placebo-Controlled, Parallel Efficacy Laboratory Classroom Study With KP415 in Children With Attention-Deficit/Hyperactivity Disorder
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
KP415 Classroom Study in Children (6-12 Years of Age) With ADHD
Updated: 12/31/1969
A Multicenter, Dose-Optimized, Double-Blind, Randomized, Placebo-Controlled, Parallel Efficacy Laboratory Classroom Study With KP415 in Children With Attention-Deficit/Hyperactivity Disorder
Status: Enrolling
Updated: 12/31/1969
KP415 Classroom Study in Children (6-12 Years of Age) With ADHD
Updated: 12/31/1969
A Multicenter, Dose-Optimized, Double-Blind, Randomized, Placebo-Controlled, Parallel Efficacy Laboratory Classroom Study With KP415 in Children With Attention-Deficit/Hyperactivity Disorder
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
KP415 Classroom Study in Children (6-12 Years of Age) With ADHD
Updated: 12/31/1969
A Multicenter, Dose-Optimized, Double-Blind, Randomized, Placebo-Controlled, Parallel Efficacy Laboratory Classroom Study With KP415 in Children With Attention-Deficit/Hyperactivity Disorder
Status: Enrolling
Updated: 12/31/1969
KP415 Classroom Study in Children (6-12 Years of Age) With ADHD
Updated: 12/31/1969
A Multicenter, Dose-Optimized, Double-Blind, Randomized, Placebo-Controlled, Parallel Efficacy Laboratory Classroom Study With KP415 in Children With Attention-Deficit/Hyperactivity Disorder
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
KP415 Classroom Study in Children (6-12 Years of Age) With ADHD
Updated: 12/31/1969
A Multicenter, Dose-Optimized, Double-Blind, Randomized, Placebo-Controlled, Parallel Efficacy Laboratory Classroom Study With KP415 in Children With Attention-Deficit/Hyperactivity Disorder
Status: Enrolling
Updated: 12/31/1969
KP415 Classroom Study in Children (6-12 Years of Age) With ADHD
Updated: 12/31/1969
A Multicenter, Dose-Optimized, Double-Blind, Randomized, Placebo-Controlled, Parallel Efficacy Laboratory Classroom Study With KP415 in Children With Attention-Deficit/Hyperactivity Disorder
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
KP415 Classroom Study in Children (6-12 Years of Age) With ADHD
Updated: 12/31/1969
A Multicenter, Dose-Optimized, Double-Blind, Randomized, Placebo-Controlled, Parallel Efficacy Laboratory Classroom Study With KP415 in Children With Attention-Deficit/Hyperactivity Disorder
Status: Enrolling
Updated: 12/31/1969
KP415 Classroom Study in Children (6-12 Years of Age) With ADHD
Updated: 12/31/1969
A Multicenter, Dose-Optimized, Double-Blind, Randomized, Placebo-Controlled, Parallel Efficacy Laboratory Classroom Study With KP415 in Children With Attention-Deficit/Hyperactivity Disorder
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Prasterone (DHEA) for the Treatment of Hypoactive Sexual Desire Disorder (HSDD)
Updated: 12/31/1969
Prasterone (DHEA) for the Treatment of Hypoactive Sexual Desire Disorder (HSDD) - (Placebo-Controlled, Double Blind and Randomized Phase III Study of Intravaginal Prasterone)
Status: Enrolling
Updated: 12/31/1969
Prasterone (DHEA) for the Treatment of Hypoactive Sexual Desire Disorder (HSDD)
Updated: 12/31/1969
Prasterone (DHEA) for the Treatment of Hypoactive Sexual Desire Disorder (HSDD) - (Placebo-Controlled, Double Blind and Randomized Phase III Study of Intravaginal Prasterone)
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Prasterone (DHEA) for the Treatment of Hypoactive Sexual Desire Disorder (HSDD)
Updated: 12/31/1969
Prasterone (DHEA) for the Treatment of Hypoactive Sexual Desire Disorder (HSDD) - (Placebo-Controlled, Double Blind and Randomized Phase III Study of Intravaginal Prasterone)
Status: Enrolling
Updated: 12/31/1969
Prasterone (DHEA) for the Treatment of Hypoactive Sexual Desire Disorder (HSDD)
Updated: 12/31/1969
Prasterone (DHEA) for the Treatment of Hypoactive Sexual Desire Disorder (HSDD) - (Placebo-Controlled, Double Blind and Randomized Phase III Study of Intravaginal Prasterone)
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Prasterone (DHEA) for the Treatment of Hypoactive Sexual Desire Disorder (HSDD)
Updated: 12/31/1969
Prasterone (DHEA) for the Treatment of Hypoactive Sexual Desire Disorder (HSDD) - (Placebo-Controlled, Double Blind and Randomized Phase III Study of Intravaginal Prasterone)
Status: Enrolling
Updated: 12/31/1969
Prasterone (DHEA) for the Treatment of Hypoactive Sexual Desire Disorder (HSDD)
Updated: 12/31/1969
Prasterone (DHEA) for the Treatment of Hypoactive Sexual Desire Disorder (HSDD) - (Placebo-Controlled, Double Blind and Randomized Phase III Study of Intravaginal Prasterone)
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Prasterone (DHEA) for the Treatment of Hypoactive Sexual Desire Disorder (HSDD)
Updated: 12/31/1969
Prasterone (DHEA) for the Treatment of Hypoactive Sexual Desire Disorder (HSDD) - (Placebo-Controlled, Double Blind and Randomized Phase III Study of Intravaginal Prasterone)
Status: Enrolling
Updated: 12/31/1969
Prasterone (DHEA) for the Treatment of Hypoactive Sexual Desire Disorder (HSDD)
Updated: 12/31/1969
Prasterone (DHEA) for the Treatment of Hypoactive Sexual Desire Disorder (HSDD) - (Placebo-Controlled, Double Blind and Randomized Phase III Study of Intravaginal Prasterone)
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Prasterone (DHEA) for the Treatment of Hypoactive Sexual Desire Disorder (HSDD)
Updated: 12/31/1969
Prasterone (DHEA) for the Treatment of Hypoactive Sexual Desire Disorder (HSDD) - (Placebo-Controlled, Double Blind and Randomized Phase III Study of Intravaginal Prasterone)
Status: Enrolling
Updated: 12/31/1969
Prasterone (DHEA) for the Treatment of Hypoactive Sexual Desire Disorder (HSDD)
Updated: 12/31/1969
Prasterone (DHEA) for the Treatment of Hypoactive Sexual Desire Disorder (HSDD) - (Placebo-Controlled, Double Blind and Randomized Phase III Study of Intravaginal Prasterone)
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Prasterone (DHEA) for the Treatment of Hypoactive Sexual Desire Disorder (HSDD)
Updated: 12/31/1969
Prasterone (DHEA) for the Treatment of Hypoactive Sexual Desire Disorder (HSDD) - (Placebo-Controlled, Double Blind and Randomized Phase III Study of Intravaginal Prasterone)
Status: Enrolling
Updated: 12/31/1969
Prasterone (DHEA) for the Treatment of Hypoactive Sexual Desire Disorder (HSDD)
Updated: 12/31/1969
Prasterone (DHEA) for the Treatment of Hypoactive Sexual Desire Disorder (HSDD) - (Placebo-Controlled, Double Blind and Randomized Phase III Study of Intravaginal Prasterone)
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Prasterone (DHEA) for the Treatment of Hypoactive Sexual Desire Disorder (HSDD)
Updated: 12/31/1969
Prasterone (DHEA) for the Treatment of Hypoactive Sexual Desire Disorder (HSDD) - (Placebo-Controlled, Double Blind and Randomized Phase III Study of Intravaginal Prasterone)
Status: Enrolling
Updated: 12/31/1969
Prasterone (DHEA) for the Treatment of Hypoactive Sexual Desire Disorder (HSDD)
Updated: 12/31/1969
Prasterone (DHEA) for the Treatment of Hypoactive Sexual Desire Disorder (HSDD) - (Placebo-Controlled, Double Blind and Randomized Phase III Study of Intravaginal Prasterone)
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Prasterone (DHEA) for the Treatment of Hypoactive Sexual Desire Disorder (HSDD)
Updated: 12/31/1969
Prasterone (DHEA) for the Treatment of Hypoactive Sexual Desire Disorder (HSDD) - (Placebo-Controlled, Double Blind and Randomized Phase III Study of Intravaginal Prasterone)
Status: Enrolling
Updated: 12/31/1969
Prasterone (DHEA) for the Treatment of Hypoactive Sexual Desire Disorder (HSDD)
Updated: 12/31/1969
Prasterone (DHEA) for the Treatment of Hypoactive Sexual Desire Disorder (HSDD) - (Placebo-Controlled, Double Blind and Randomized Phase III Study of Intravaginal Prasterone)
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Prasterone (DHEA) for the Treatment of Hypoactive Sexual Desire Disorder (HSDD)
Updated: 12/31/1969
Prasterone (DHEA) for the Treatment of Hypoactive Sexual Desire Disorder (HSDD) - (Placebo-Controlled, Double Blind and Randomized Phase III Study of Intravaginal Prasterone)
Status: Enrolling
Updated: 12/31/1969
Prasterone (DHEA) for the Treatment of Hypoactive Sexual Desire Disorder (HSDD)
Updated: 12/31/1969
Prasterone (DHEA) for the Treatment of Hypoactive Sexual Desire Disorder (HSDD) - (Placebo-Controlled, Double Blind and Randomized Phase III Study of Intravaginal Prasterone)
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Prasterone (DHEA) for the Treatment of Hypoactive Sexual Desire Disorder (HSDD)
Updated: 12/31/1969
Prasterone (DHEA) for the Treatment of Hypoactive Sexual Desire Disorder (HSDD) - (Placebo-Controlled, Double Blind and Randomized Phase III Study of Intravaginal Prasterone)
Status: Enrolling
Updated: 12/31/1969
Prasterone (DHEA) for the Treatment of Hypoactive Sexual Desire Disorder (HSDD)
Updated: 12/31/1969
Prasterone (DHEA) for the Treatment of Hypoactive Sexual Desire Disorder (HSDD) - (Placebo-Controlled, Double Blind and Randomized Phase III Study of Intravaginal Prasterone)
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Prasterone (DHEA) for the Treatment of Hypoactive Sexual Desire Disorder (HSDD)
Updated: 12/31/1969
Prasterone (DHEA) for the Treatment of Hypoactive Sexual Desire Disorder (HSDD) - (Placebo-Controlled, Double Blind and Randomized Phase III Study of Intravaginal Prasterone)
Status: Enrolling
Updated: 12/31/1969
Prasterone (DHEA) for the Treatment of Hypoactive Sexual Desire Disorder (HSDD)
Updated: 12/31/1969
Prasterone (DHEA) for the Treatment of Hypoactive Sexual Desire Disorder (HSDD) - (Placebo-Controlled, Double Blind and Randomized Phase III Study of Intravaginal Prasterone)
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Prasterone (DHEA) for the Treatment of Hypoactive Sexual Desire Disorder (HSDD)
Updated: 12/31/1969
Prasterone (DHEA) for the Treatment of Hypoactive Sexual Desire Disorder (HSDD) - (Placebo-Controlled, Double Blind and Randomized Phase III Study of Intravaginal Prasterone)
Status: Enrolling
Updated: 12/31/1969
Prasterone (DHEA) for the Treatment of Hypoactive Sexual Desire Disorder (HSDD)
Updated: 12/31/1969
Prasterone (DHEA) for the Treatment of Hypoactive Sexual Desire Disorder (HSDD) - (Placebo-Controlled, Double Blind and Randomized Phase III Study of Intravaginal Prasterone)
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Prasterone (DHEA) for the Treatment of Hypoactive Sexual Desire Disorder (HSDD)
Updated: 12/31/1969
Prasterone (DHEA) for the Treatment of Hypoactive Sexual Desire Disorder (HSDD) - (Placebo-Controlled, Double Blind and Randomized Phase III Study of Intravaginal Prasterone)
Status: Enrolling
Updated: 12/31/1969
Prasterone (DHEA) for the Treatment of Hypoactive Sexual Desire Disorder (HSDD)
Updated: 12/31/1969
Prasterone (DHEA) for the Treatment of Hypoactive Sexual Desire Disorder (HSDD) - (Placebo-Controlled, Double Blind and Randomized Phase III Study of Intravaginal Prasterone)
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Prasterone (DHEA) for the Treatment of Hypoactive Sexual Desire Disorder (HSDD)
Updated: 12/31/1969
Prasterone (DHEA) for the Treatment of Hypoactive Sexual Desire Disorder (HSDD) - (Placebo-Controlled, Double Blind and Randomized Phase III Study of Intravaginal Prasterone)
Status: Enrolling
Updated: 12/31/1969
Prasterone (DHEA) for the Treatment of Hypoactive Sexual Desire Disorder (HSDD)
Updated: 12/31/1969
Prasterone (DHEA) for the Treatment of Hypoactive Sexual Desire Disorder (HSDD) - (Placebo-Controlled, Double Blind and Randomized Phase III Study of Intravaginal Prasterone)
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Prasterone (DHEA) for the Treatment of Hypoactive Sexual Desire Disorder (HSDD)
Updated: 12/31/1969
Prasterone (DHEA) for the Treatment of Hypoactive Sexual Desire Disorder (HSDD) - (Placebo-Controlled, Double Blind and Randomized Phase III Study of Intravaginal Prasterone)
Status: Enrolling
Updated: 12/31/1969
Prasterone (DHEA) for the Treatment of Hypoactive Sexual Desire Disorder (HSDD)
Updated: 12/31/1969
Prasterone (DHEA) for the Treatment of Hypoactive Sexual Desire Disorder (HSDD) - (Placebo-Controlled, Double Blind and Randomized Phase III Study of Intravaginal Prasterone)
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Prasterone (DHEA) for the Treatment of Hypoactive Sexual Desire Disorder (HSDD)
Updated: 12/31/1969
Prasterone (DHEA) for the Treatment of Hypoactive Sexual Desire Disorder (HSDD) - (Placebo-Controlled, Double Blind and Randomized Phase III Study of Intravaginal Prasterone)
Status: Enrolling
Updated: 12/31/1969
Prasterone (DHEA) for the Treatment of Hypoactive Sexual Desire Disorder (HSDD)
Updated: 12/31/1969
Prasterone (DHEA) for the Treatment of Hypoactive Sexual Desire Disorder (HSDD) - (Placebo-Controlled, Double Blind and Randomized Phase III Study of Intravaginal Prasterone)
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Prasterone (DHEA) for the Treatment of Hypoactive Sexual Desire Disorder (HSDD)
Updated: 12/31/1969
Prasterone (DHEA) for the Treatment of Hypoactive Sexual Desire Disorder (HSDD) - (Placebo-Controlled, Double Blind and Randomized Phase III Study of Intravaginal Prasterone)
Status: Enrolling
Updated: 12/31/1969
Prasterone (DHEA) for the Treatment of Hypoactive Sexual Desire Disorder (HSDD)
Updated: 12/31/1969
Prasterone (DHEA) for the Treatment of Hypoactive Sexual Desire Disorder (HSDD) - (Placebo-Controlled, Double Blind and Randomized Phase III Study of Intravaginal Prasterone)
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Prasterone (DHEA) for the Treatment of Hypoactive Sexual Desire Disorder (HSDD)
Updated: 12/31/1969
Prasterone (DHEA) for the Treatment of Hypoactive Sexual Desire Disorder (HSDD) - (Placebo-Controlled, Double Blind and Randomized Phase III Study of Intravaginal Prasterone)
Status: Enrolling
Updated: 12/31/1969
Prasterone (DHEA) for the Treatment of Hypoactive Sexual Desire Disorder (HSDD)
Updated: 12/31/1969
Prasterone (DHEA) for the Treatment of Hypoactive Sexual Desire Disorder (HSDD) - (Placebo-Controlled, Double Blind and Randomized Phase III Study of Intravaginal Prasterone)
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Prasterone (DHEA) for the Treatment of Hypoactive Sexual Desire Disorder (HSDD)
Updated: 12/31/1969
Prasterone (DHEA) for the Treatment of Hypoactive Sexual Desire Disorder (HSDD) - (Placebo-Controlled, Double Blind and Randomized Phase III Study of Intravaginal Prasterone)
Status: Enrolling
Updated: 12/31/1969
Prasterone (DHEA) for the Treatment of Hypoactive Sexual Desire Disorder (HSDD)
Updated: 12/31/1969
Prasterone (DHEA) for the Treatment of Hypoactive Sexual Desire Disorder (HSDD) - (Placebo-Controlled, Double Blind and Randomized Phase III Study of Intravaginal Prasterone)
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Prasterone (DHEA) for the Treatment of Hypoactive Sexual Desire Disorder (HSDD)
Updated: 12/31/1969
Prasterone (DHEA) for the Treatment of Hypoactive Sexual Desire Disorder (HSDD) - (Placebo-Controlled, Double Blind and Randomized Phase III Study of Intravaginal Prasterone)
Status: Enrolling
Updated: 12/31/1969
Prasterone (DHEA) for the Treatment of Hypoactive Sexual Desire Disorder (HSDD)
Updated: 12/31/1969
Prasterone (DHEA) for the Treatment of Hypoactive Sexual Desire Disorder (HSDD) - (Placebo-Controlled, Double Blind and Randomized Phase III Study of Intravaginal Prasterone)
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Prasterone (DHEA) for the Treatment of Hypoactive Sexual Desire Disorder (HSDD)
Updated: 12/31/1969
Prasterone (DHEA) for the Treatment of Hypoactive Sexual Desire Disorder (HSDD) - (Placebo-Controlled, Double Blind and Randomized Phase III Study of Intravaginal Prasterone)
Status: Enrolling
Updated: 12/31/1969
Prasterone (DHEA) for the Treatment of Hypoactive Sexual Desire Disorder (HSDD)
Updated: 12/31/1969
Prasterone (DHEA) for the Treatment of Hypoactive Sexual Desire Disorder (HSDD) - (Placebo-Controlled, Double Blind and Randomized Phase III Study of Intravaginal Prasterone)
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Prasterone (DHEA) for the Treatment of Hypoactive Sexual Desire Disorder (HSDD)
Updated: 12/31/1969
Prasterone (DHEA) for the Treatment of Hypoactive Sexual Desire Disorder (HSDD) - (Placebo-Controlled, Double Blind and Randomized Phase III Study of Intravaginal Prasterone)
Status: Enrolling
Updated: 12/31/1969
Prasterone (DHEA) for the Treatment of Hypoactive Sexual Desire Disorder (HSDD)
Updated: 12/31/1969
Prasterone (DHEA) for the Treatment of Hypoactive Sexual Desire Disorder (HSDD) - (Placebo-Controlled, Double Blind and Randomized Phase III Study of Intravaginal Prasterone)
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Prasterone (DHEA) for the Treatment of Hypoactive Sexual Desire Disorder (HSDD)
Updated: 12/31/1969
Prasterone (DHEA) for the Treatment of Hypoactive Sexual Desire Disorder (HSDD) - (Placebo-Controlled, Double Blind and Randomized Phase III Study of Intravaginal Prasterone)
Status: Enrolling
Updated: 12/31/1969
Prasterone (DHEA) for the Treatment of Hypoactive Sexual Desire Disorder (HSDD)
Updated: 12/31/1969
Prasterone (DHEA) for the Treatment of Hypoactive Sexual Desire Disorder (HSDD) - (Placebo-Controlled, Double Blind and Randomized Phase III Study of Intravaginal Prasterone)
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Prasterone (DHEA) for the Treatment of Hypoactive Sexual Desire Disorder (HSDD)
Updated: 12/31/1969
Prasterone (DHEA) for the Treatment of Hypoactive Sexual Desire Disorder (HSDD) - (Placebo-Controlled, Double Blind and Randomized Phase III Study of Intravaginal Prasterone)
Status: Enrolling
Updated: 12/31/1969
Prasterone (DHEA) for the Treatment of Hypoactive Sexual Desire Disorder (HSDD)
Updated: 12/31/1969
Prasterone (DHEA) for the Treatment of Hypoactive Sexual Desire Disorder (HSDD) - (Placebo-Controlled, Double Blind and Randomized Phase III Study of Intravaginal Prasterone)
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Prasterone (DHEA) for the Treatment of Hypoactive Sexual Desire Disorder (HSDD)
Updated: 12/31/1969
Prasterone (DHEA) for the Treatment of Hypoactive Sexual Desire Disorder (HSDD) - (Placebo-Controlled, Double Blind and Randomized Phase III Study of Intravaginal Prasterone)
Status: Enrolling
Updated: 12/31/1969
Prasterone (DHEA) for the Treatment of Hypoactive Sexual Desire Disorder (HSDD)
Updated: 12/31/1969
Prasterone (DHEA) for the Treatment of Hypoactive Sexual Desire Disorder (HSDD) - (Placebo-Controlled, Double Blind and Randomized Phase III Study of Intravaginal Prasterone)
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Prasterone (DHEA) for the Treatment of Hypoactive Sexual Desire Disorder (HSDD)
Updated: 12/31/1969
Prasterone (DHEA) for the Treatment of Hypoactive Sexual Desire Disorder (HSDD) - (Placebo-Controlled, Double Blind and Randomized Phase III Study of Intravaginal Prasterone)
Status: Enrolling
Updated: 12/31/1969
Prasterone (DHEA) for the Treatment of Hypoactive Sexual Desire Disorder (HSDD)
Updated: 12/31/1969
Prasterone (DHEA) for the Treatment of Hypoactive Sexual Desire Disorder (HSDD) - (Placebo-Controlled, Double Blind and Randomized Phase III Study of Intravaginal Prasterone)
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Prasterone (DHEA) for the Treatment of Hypoactive Sexual Desire Disorder (HSDD)
Updated: 12/31/1969
Prasterone (DHEA) for the Treatment of Hypoactive Sexual Desire Disorder (HSDD) - (Placebo-Controlled, Double Blind and Randomized Phase III Study of Intravaginal Prasterone)
Status: Enrolling
Updated: 12/31/1969
Prasterone (DHEA) for the Treatment of Hypoactive Sexual Desire Disorder (HSDD)
Updated: 12/31/1969
Prasterone (DHEA) for the Treatment of Hypoactive Sexual Desire Disorder (HSDD) - (Placebo-Controlled, Double Blind and Randomized Phase III Study of Intravaginal Prasterone)
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Prasterone (DHEA) for the Treatment of Hypoactive Sexual Desire Disorder (HSDD)
Updated: 12/31/1969
Prasterone (DHEA) for the Treatment of Hypoactive Sexual Desire Disorder (HSDD) - (Placebo-Controlled, Double Blind and Randomized Phase III Study of Intravaginal Prasterone)
Status: Enrolling
Updated: 12/31/1969
Prasterone (DHEA) for the Treatment of Hypoactive Sexual Desire Disorder (HSDD)
Updated: 12/31/1969
Prasterone (DHEA) for the Treatment of Hypoactive Sexual Desire Disorder (HSDD) - (Placebo-Controlled, Double Blind and Randomized Phase III Study of Intravaginal Prasterone)
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Prasterone (DHEA) for the Treatment of Hypoactive Sexual Desire Disorder (HSDD)
Updated: 12/31/1969
Prasterone (DHEA) for the Treatment of Hypoactive Sexual Desire Disorder (HSDD) - (Placebo-Controlled, Double Blind and Randomized Phase III Study of Intravaginal Prasterone)
Status: Enrolling
Updated: 12/31/1969
Prasterone (DHEA) for the Treatment of Hypoactive Sexual Desire Disorder (HSDD)
Updated: 12/31/1969
Prasterone (DHEA) for the Treatment of Hypoactive Sexual Desire Disorder (HSDD) - (Placebo-Controlled, Double Blind and Randomized Phase III Study of Intravaginal Prasterone)
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Prasterone (DHEA) for the Treatment of Hypoactive Sexual Desire Disorder (HSDD)
Updated: 12/31/1969
Prasterone (DHEA) for the Treatment of Hypoactive Sexual Desire Disorder (HSDD) - (Placebo-Controlled, Double Blind and Randomized Phase III Study of Intravaginal Prasterone)
Status: Enrolling
Updated: 12/31/1969
Prasterone (DHEA) for the Treatment of Hypoactive Sexual Desire Disorder (HSDD)
Updated: 12/31/1969
Prasterone (DHEA) for the Treatment of Hypoactive Sexual Desire Disorder (HSDD) - (Placebo-Controlled, Double Blind and Randomized Phase III Study of Intravaginal Prasterone)
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Prasterone (DHEA) for the Treatment of Hypoactive Sexual Desire Disorder (HSDD)
Updated: 12/31/1969
Prasterone (DHEA) for the Treatment of Hypoactive Sexual Desire Disorder (HSDD) - (Placebo-Controlled, Double Blind and Randomized Phase III Study of Intravaginal Prasterone)
Status: Enrolling
Updated: 12/31/1969
Prasterone (DHEA) for the Treatment of Hypoactive Sexual Desire Disorder (HSDD)
Updated: 12/31/1969
Prasterone (DHEA) for the Treatment of Hypoactive Sexual Desire Disorder (HSDD) - (Placebo-Controlled, Double Blind and Randomized Phase III Study of Intravaginal Prasterone)
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Prasterone (DHEA) for the Treatment of Hypoactive Sexual Desire Disorder (HSDD)
Updated: 12/31/1969
Prasterone (DHEA) for the Treatment of Hypoactive Sexual Desire Disorder (HSDD) - (Placebo-Controlled, Double Blind and Randomized Phase III Study of Intravaginal Prasterone)
Status: Enrolling
Updated: 12/31/1969
Prasterone (DHEA) for the Treatment of Hypoactive Sexual Desire Disorder (HSDD)
Updated: 12/31/1969
Prasterone (DHEA) for the Treatment of Hypoactive Sexual Desire Disorder (HSDD) - (Placebo-Controlled, Double Blind and Randomized Phase III Study of Intravaginal Prasterone)
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Prasterone (DHEA) for the Treatment of Hypoactive Sexual Desire Disorder (HSDD)
Updated: 12/31/1969
Prasterone (DHEA) for the Treatment of Hypoactive Sexual Desire Disorder (HSDD) - (Placebo-Controlled, Double Blind and Randomized Phase III Study of Intravaginal Prasterone)
Status: Enrolling
Updated: 12/31/1969
Prasterone (DHEA) for the Treatment of Hypoactive Sexual Desire Disorder (HSDD)
Updated: 12/31/1969
Prasterone (DHEA) for the Treatment of Hypoactive Sexual Desire Disorder (HSDD) - (Placebo-Controlled, Double Blind and Randomized Phase III Study of Intravaginal Prasterone)
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Prasterone (DHEA) for the Treatment of Hypoactive Sexual Desire Disorder (HSDD)
Updated: 12/31/1969
Prasterone (DHEA) for the Treatment of Hypoactive Sexual Desire Disorder (HSDD) - (Placebo-Controlled, Double Blind and Randomized Phase III Study of Intravaginal Prasterone)
Status: Enrolling
Updated: 12/31/1969
Prasterone (DHEA) for the Treatment of Hypoactive Sexual Desire Disorder (HSDD)
Updated: 12/31/1969
Prasterone (DHEA) for the Treatment of Hypoactive Sexual Desire Disorder (HSDD) - (Placebo-Controlled, Double Blind and Randomized Phase III Study of Intravaginal Prasterone)
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Prasterone (DHEA) for the Treatment of Hypoactive Sexual Desire Disorder (HSDD)
Updated: 12/31/1969
Prasterone (DHEA) for the Treatment of Hypoactive Sexual Desire Disorder (HSDD) - (Placebo-Controlled, Double Blind and Randomized Phase III Study of Intravaginal Prasterone)
Status: Enrolling
Updated: 12/31/1969
Prasterone (DHEA) for the Treatment of Hypoactive Sexual Desire Disorder (HSDD)
Updated: 12/31/1969
Prasterone (DHEA) for the Treatment of Hypoactive Sexual Desire Disorder (HSDD) - (Placebo-Controlled, Double Blind and Randomized Phase III Study of Intravaginal Prasterone)
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Prasterone (DHEA) for the Treatment of Hypoactive Sexual Desire Disorder (HSDD)
Updated: 12/31/1969
Prasterone (DHEA) for the Treatment of Hypoactive Sexual Desire Disorder (HSDD) - (Placebo-Controlled, Double Blind and Randomized Phase III Study of Intravaginal Prasterone)
Status: Enrolling
Updated: 12/31/1969
Prasterone (DHEA) for the Treatment of Hypoactive Sexual Desire Disorder (HSDD)
Updated: 12/31/1969
Prasterone (DHEA) for the Treatment of Hypoactive Sexual Desire Disorder (HSDD) - (Placebo-Controlled, Double Blind and Randomized Phase III Study of Intravaginal Prasterone)
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Prasterone (DHEA) for the Treatment of Hypoactive Sexual Desire Disorder (HSDD)
Updated: 12/31/1969
Prasterone (DHEA) for the Treatment of Hypoactive Sexual Desire Disorder (HSDD) - (Placebo-Controlled, Double Blind and Randomized Phase III Study of Intravaginal Prasterone)
Status: Enrolling
Updated: 12/31/1969
Prasterone (DHEA) for the Treatment of Hypoactive Sexual Desire Disorder (HSDD)
Updated: 12/31/1969
Prasterone (DHEA) for the Treatment of Hypoactive Sexual Desire Disorder (HSDD) - (Placebo-Controlled, Double Blind and Randomized Phase III Study of Intravaginal Prasterone)
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Prasterone (DHEA) for the Treatment of Hypoactive Sexual Desire Disorder (HSDD)
Updated: 12/31/1969
Prasterone (DHEA) for the Treatment of Hypoactive Sexual Desire Disorder (HSDD) - (Placebo-Controlled, Double Blind and Randomized Phase III Study of Intravaginal Prasterone)
Status: Enrolling
Updated: 12/31/1969
Prasterone (DHEA) for the Treatment of Hypoactive Sexual Desire Disorder (HSDD)
Updated: 12/31/1969
Prasterone (DHEA) for the Treatment of Hypoactive Sexual Desire Disorder (HSDD) - (Placebo-Controlled, Double Blind and Randomized Phase III Study of Intravaginal Prasterone)
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Prasterone (DHEA) for the Treatment of Hypoactive Sexual Desire Disorder (HSDD)
Updated: 12/31/1969
Prasterone (DHEA) for the Treatment of Hypoactive Sexual Desire Disorder (HSDD) - (Placebo-Controlled, Double Blind and Randomized Phase III Study of Intravaginal Prasterone)
Status: Enrolling
Updated: 12/31/1969
Prasterone (DHEA) for the Treatment of Hypoactive Sexual Desire Disorder (HSDD)
Updated: 12/31/1969
Prasterone (DHEA) for the Treatment of Hypoactive Sexual Desire Disorder (HSDD) - (Placebo-Controlled, Double Blind and Randomized Phase III Study of Intravaginal Prasterone)
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Prasterone (DHEA) for the Treatment of Hypoactive Sexual Desire Disorder (HSDD)
Updated: 12/31/1969
Prasterone (DHEA) for the Treatment of Hypoactive Sexual Desire Disorder (HSDD) - (Placebo-Controlled, Double Blind and Randomized Phase III Study of Intravaginal Prasterone)
Status: Enrolling
Updated: 12/31/1969
Prasterone (DHEA) for the Treatment of Hypoactive Sexual Desire Disorder (HSDD)
Updated: 12/31/1969
Prasterone (DHEA) for the Treatment of Hypoactive Sexual Desire Disorder (HSDD) - (Placebo-Controlled, Double Blind and Randomized Phase III Study of Intravaginal Prasterone)
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Prasterone (DHEA) for the Treatment of Hypoactive Sexual Desire Disorder (HSDD)
Updated: 12/31/1969
Prasterone (DHEA) for the Treatment of Hypoactive Sexual Desire Disorder (HSDD) - (Placebo-Controlled, Double Blind and Randomized Phase III Study of Intravaginal Prasterone)
Status: Enrolling
Updated: 12/31/1969
Prasterone (DHEA) for the Treatment of Hypoactive Sexual Desire Disorder (HSDD)
Updated: 12/31/1969
Prasterone (DHEA) for the Treatment of Hypoactive Sexual Desire Disorder (HSDD) - (Placebo-Controlled, Double Blind and Randomized Phase III Study of Intravaginal Prasterone)
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Prasterone (DHEA) for the Treatment of Hypoactive Sexual Desire Disorder (HSDD)
Updated: 12/31/1969
Prasterone (DHEA) for the Treatment of Hypoactive Sexual Desire Disorder (HSDD) - (Placebo-Controlled, Double Blind and Randomized Phase III Study of Intravaginal Prasterone)
Status: Enrolling
Updated: 12/31/1969
Prasterone (DHEA) for the Treatment of Hypoactive Sexual Desire Disorder (HSDD)
Updated: 12/31/1969
Prasterone (DHEA) for the Treatment of Hypoactive Sexual Desire Disorder (HSDD) - (Placebo-Controlled, Double Blind and Randomized Phase III Study of Intravaginal Prasterone)
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Prasterone (DHEA) for the Treatment of Hypoactive Sexual Desire Disorder (HSDD)
Updated: 12/31/1969
Prasterone (DHEA) for the Treatment of Hypoactive Sexual Desire Disorder (HSDD) - (Placebo-Controlled, Double Blind and Randomized Phase III Study of Intravaginal Prasterone)
Status: Enrolling
Updated: 12/31/1969
Prasterone (DHEA) for the Treatment of Hypoactive Sexual Desire Disorder (HSDD)
Updated: 12/31/1969
Prasterone (DHEA) for the Treatment of Hypoactive Sexual Desire Disorder (HSDD) - (Placebo-Controlled, Double Blind and Randomized Phase III Study of Intravaginal Prasterone)
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Prasterone (DHEA) for the Treatment of Hypoactive Sexual Desire Disorder (HSDD)
Updated: 12/31/1969
Prasterone (DHEA) for the Treatment of Hypoactive Sexual Desire Disorder (HSDD) - (Placebo-Controlled, Double Blind and Randomized Phase III Study of Intravaginal Prasterone)
Status: Enrolling
Updated: 12/31/1969
Prasterone (DHEA) for the Treatment of Hypoactive Sexual Desire Disorder (HSDD)
Updated: 12/31/1969
Prasterone (DHEA) for the Treatment of Hypoactive Sexual Desire Disorder (HSDD) - (Placebo-Controlled, Double Blind and Randomized Phase III Study of Intravaginal Prasterone)
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials